Nutrition Science

Vitamin D and Mortality: What Trials Really Found

Does vitamin D lower the risk of death? See what the VITAL trial and other large randomized trials really found about vitamin D supplements and mortality.

Published July 19, 2026 Author: Yanni Papoutsis Reviewed against peer-reviewed sources
Grilled salmon fillet, a source of omega-3 fatty acids
Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult your physician before making dietary changes.

Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult your physician before making dietary changes or starting supplements.

TL;DR

Vitamin D is one of the most studied supplements in longevity, with a striking gap between observational data, where low vitamin D levels are strongly associated with higher mortality, and randomized trials, where supplementing generally healthy, vitamin-D-replete adults has shown little or no effect on the risk of death or major cardiovascular events. In the large VITAL trial, 25,871 US adults were randomized to 2,000 IU per day of vitamin D3 or placebo, and after about five years there was no significant reduction in the primary endpoints of invasive cancer (hazard ratio 0.96, 95% CI 0.88 to 1.06) or major cardiovascular events (hazard ratio 0.97, 95% CI 0.85 to 1.12) [Manson et al., 2019, New England Journal of Medicine]. A secondary analysis suggested a possible reduction in cancer death over time, and later analyses suggested a possible reduction in advanced (metastatic or fatal) cancer, particularly among people with normal body weight. Meta-analyses of vitamin D trials have generally found little effect on all-cause mortality overall, though some have reported a modest reduction in cancer mortality. The most likely interpretation is that vitamin D acts as a marker of overall health in observational studies, and that correcting genuine deficiency matters, while routine high-dose supplementation of already-replete people does not clearly extend life.

Does Taking Vitamin D Lower Your Risk of Death?

For most generally healthy adults who are not deficient, the large randomized trials suggest that routine vitamin D supplementation does not meaningfully lower the risk of death or major cardiovascular events. The strong link between low vitamin D and higher mortality seen in observational studies appears to be substantially driven by reverse causation and confounding: people who are sick, frail, or inactive tend to have lower vitamin D levels, rather than low vitamin D itself causing most of the excess deaths. Correcting true deficiency is still important for bone and muscle health.

Why Do Observational Studies and Trials Disagree So Much?

This is one of the clearest examples in nutrition of observational and randomized evidence pointing in different directions. Dozens of cohort studies have found that people with low blood levels of vitamin D (25-hydroxyvitamin D) have higher rates of cardiovascular disease, cancer, and death. But blood vitamin D is influenced by sun exposure, physical activity, body weight, and overall health, so sick and sedentary people naturally have lower levels. When randomized trials give vitamin D to correct this, the mortality benefit largely fails to appear, which strongly suggests the observational association was mostly a marker of health rather than a cause of disease.

What Did the VITAL Trial Find?

The VITAL trial is the largest and most rigorous test of vitamin D for disease prevention in generally healthy adults. It randomized 25,871 US men aged 50 and older and women aged 55 and older to 2,000 IU per day of vitamin D3 or placebo, in a factorial design that also tested omega-3 fatty acids [Manson et al., 2019, New England Journal of Medicine]. Participants were not selected for deficiency; most had adequate baseline levels. Over a median of about 5.3 years, vitamin D did not significantly reduce the co-primary endpoints of invasive cancer (hazard ratio 0.96) or major cardiovascular events (hazard ratio 0.97). All-cause mortality was not significantly different between groups. Some secondary and later analyses suggested a possible reduction in cancer death when early follow-up was excluded, and a possible reduction in advanced or fatal cancer, especially in participants with normal body weight, but these were secondary findings requiring confirmation.

What Do Other Trials and Meta-Analyses Show?

Other large trials, including the Australian D-Health trial of monthly high-dose vitamin D in older adults, have similarly found no significant reduction in all-cause mortality overall. Meta-analyses pooling many vitamin D trials have generally concluded that supplementation has little or no effect on all-cause mortality, though some have reported a modest reduction specifically in cancer mortality, on the order of a few percent, which remains debated. The overall weight of randomized evidence does not support routine vitamin D supplementation as a longevity intervention for the general, replete population.

Does Correcting Genuine Deficiency Still Matter?

Yes, and this is an important distinction. The trials showing no mortality benefit were mostly conducted in populations that were largely vitamin-D-replete at baseline. Genuine vitamin D deficiency, particularly severe deficiency, is a real clinical problem that causes rickets in children and osteomalacia and increased fracture and falls risk in adults. People at high risk of deficiency, including those with little sun exposure, darker skin, older age, obesity, or certain medical conditions, may genuinely benefit from correcting low levels. The nuance is between correcting deficiency (worthwhile) and dosing already-adequate people in the hope of extending life (not supported by trials).

How Much Vitamin D Is Reasonable, and Can You Get Too Much?

National guidelines commonly recommend on the order of 600 to 800 IU per day for most adults, primarily for bone health, with higher upper limits considered safe for most people. Very high doses are not benign: some trials of large intermittent or high daily doses have found no benefit and occasional signals of harm, including increased falls or fractures at very high intermittent dosing. This reinforces that more is not better once levels are adequate, and that megadosing is not a validated longevity strategy.

How Does Vitamin D Fit Into a Broader Longevity Strategy?

Vitamin D illustrates a general principle: correcting a genuine deficiency is valuable, but supplements rarely replicate the benefits of overall healthy living. The interventions with the strongest longevity evidence remain physical activity, described in our exercise-for-longevity protocol, and whole-diet patterns rich in fish, nuts, and olive oil, while limiting red and processed meat. Tracking your biological age is a more meaningful gauge of progress than any single blood-level number.

Frequently Asked Questions

Does vitamin D supplementation lower the risk of death? For generally healthy, vitamin-D-replete adults, the large randomized trials including VITAL found no significant reduction in all-cause mortality or major cardiovascular events [Manson et al., 2019, New England Journal of Medicine]. Correcting genuine deficiency is a separate matter.

Why do observational studies show vitamin D helps but trials do not? Because low blood vitamin D is largely a marker of poor health, low activity, and higher body weight, rather than a primary cause of death. When trials correct the level directly, the mortality benefit largely disappears, indicating the association was mostly confounding and reverse causation.

Did VITAL show any benefit at all? The primary endpoints were not significantly reduced, but some secondary and later analyses suggested a possible reduction in cancer death and in advanced or fatal cancer, especially in people of normal body weight. These findings are secondary and need confirmation.

Should anyone take vitamin D? People with genuine deficiency or high risk of it, including those with little sun exposure, darker skin, older age, or obesity, may benefit from correcting low levels under medical guidance. Routine high-dose supplementation of already-adequate people is not supported for longevity.

Can you take too much vitamin D? Yes. Very high doses provide no added benefit once levels are adequate and, in some trials of high intermittent dosing, have been associated with increased falls or fractures. More is not better.

Calculate Your Life Expectancy

Supplements are only one small piece of the longevity picture. Calculate your life expectancy with the Death Clock to see how your overall lifestyle choices combine.

Ready to find out your life expectancy?

Use the Death Clock calculator to see how your current diet and other lifestyle factors affect your projected lifespan.

Calculate My Life Expectancy

Read more longevity research:

Exercise Protocol VO2 Max & Lifespan Nuts & Longevity Olive Oil & Lifespan